These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
464 related articles for article (PubMed ID: 15716206)
1. Do cystometric findings predict the results of intravesical hyaluronic acid in women with interstitial cystitis? Daha LK; Riedl CR; Lazar D; Hohlbrugger G; Pflüger H Eur Urol; 2005 Mar; 47(3):393-7; discussion 397. PubMed ID: 15716206 [TBL] [Abstract][Full Text] [Related]
2. Re: Daha LK, Riedl CR, Lazar D, Hohlbrugger G, Pfluger H. Do cystometric findings predict the results of intravesical hyaluronic acid in women with interstitial cystitis? Eur Urol 2005; 47: 393-7. Gupta SK Eur Urol; 2005 Sep; 48(3):534. PubMed ID: 15994004 [No Abstract] [Full Text] [Related]
3. Intravesical hyaluronic acid for interstitial cystitis/painful bladder syndrome: a comparative randomized assessment of different regimens. Lai MC; Kuo YC; Kuo HC Int J Urol; 2013 Feb; 20(2):203-7. PubMed ID: 22925498 [TBL] [Abstract][Full Text] [Related]
4. Intravesical instillation of hyaluronic acid prolonged the effect of bladder hydrodistention in patients with severe interstitial cystitis. Shao Y; Shen ZJ; Rui WB; Zhou WL Urology; 2010 Mar; 75(3):547-50. PubMed ID: 20022087 [TBL] [Abstract][Full Text] [Related]
5. Comparative assessment of maximal bladder capacity, 0.9% NaCl versus 0.2 M Kcl, for the diagnosis of interstitial cystitis: a prospective controlled study. Daha LK; Riedl CR; Hohlbrugger G; Knoll M; Engelhardt PF; Pflüger H J Urol; 2003 Sep; 170(3):807-9. PubMed ID: 12913704 [TBL] [Abstract][Full Text] [Related]
6. Intravesical hyaluronic acid in the treatment of refractory interstitial cystitis. Morales A; Emerson L; Nickel JC; Lundie M J Urol; 1996 Jul; 156(1):45-8. PubMed ID: 8648835 [TBL] [Abstract][Full Text] [Related]
7. The potassium sensitivity test: a predictor of treatment response in interstitial cystitis. Gupta SK; Pidcock L; Parr NJ BJU Int; 2005 Nov; 96(7):1063-6. PubMed ID: 16225529 [TBL] [Abstract][Full Text] [Related]
8. Effect of intravesical glycosaminoglycan substitution therapy on bladder pain syndrome/interstitial cystitis, bladder capacity and potassium sensitivity. Daha LK; Riedl CR; Lazar D; Simak R; Pflüger H Scand J Urol Nephrol; 2008; 42(4):369-72. PubMed ID: 19230170 [TBL] [Abstract][Full Text] [Related]
9. Successful downregulation of bladder sensory nerves with combination of heparin and alkalinized lidocaine in patients with interstitial cystitis. Parsons CL Urology; 2005 Jan; 65(1):45-8. PubMed ID: 15667861 [TBL] [Abstract][Full Text] [Related]
10. Urinary and psychological outcomes in women with interstitial cystitis/bladder pain syndrome following hyaluronic acid treatment. Liang CC; Lin YH; Hsieh WC; Huang L Taiwan J Obstet Gynecol; 2018 Jun; 57(3):360-363. PubMed ID: 29880165 [TBL] [Abstract][Full Text] [Related]
11. Interstitial cystitis versus detrusor overactivity: a comparative, randomized, controlled study of cystometry using saline and 0.3 M potassium chloride. Philip J; Willmott S; Irwin P J Urol; 2006 Feb; 175(2):566-70; discussion 570-1. PubMed ID: 16406997 [TBL] [Abstract][Full Text] [Related]
12. Urinary nerve growth factor level is increased in patients with interstitial cystitis/bladder pain syndrome and decreased in responders to treatment. Liu HT; Tyagi P; Chancellor MB; Kuo HC BJU Int; 2009 Nov; 104(10):1476-81. PubMed ID: 19522864 [TBL] [Abstract][Full Text] [Related]
13. Dyspareunia response in patients with interstitial cystitis treated with intravesical lidocaine, bicarbonate, and heparin. Welk BK; Teichman JM Urology; 2008 Jan; 71(1):67-70. PubMed ID: 18242367 [TBL] [Abstract][Full Text] [Related]
14. A double-blind, randomized controlled trial of cystometry using saline versus 0.3 M potassium chloride infusion in women with overactive bladder syndrome. Philip J; Willmott S; Owen D; Samsudin C; Irwin PP Neurourol Urodyn; 2007; 26(1):110-4. PubMed ID: 17009304 [TBL] [Abstract][Full Text] [Related]
15. A randomized, open-label, multicenter study of the efficacy and safety of intravesical hyaluronic acid and chondroitin sulfate versus dimethyl sulfoxide in women with bladder pain syndrome/interstitial cystitis. Cervigni M; Sommariva M; Tenaglia R; Porru D; Ostardo E; Giammò A; Trevisan S; Frangione V; Ciani O; Tarricone R; Pappagallo GL Neurourol Urodyn; 2017 Apr; 36(4):1178-1186. PubMed ID: 27654012 [TBL] [Abstract][Full Text] [Related]
16. Intravesical alkalinized lidocaine (PSD597) offers sustained relief from symptoms of interstitial cystitis and painful bladder syndrome. Nickel JC; Moldwin R; Lee S; Davis EL; Henry RA; Wyllie MG BJU Int; 2009 Apr; 103(7):910-8. PubMed ID: 19021619 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of urinary and general symptoms and correlation with other clinical parameters in interstitial cystitis patients. Porru D; Tinelli C; Gerardini M; Giliberto GL; Stancati S; Rovereto B Neurourol Urodyn; 2005; 24(1):69-73. PubMed ID: 15573384 [TBL] [Abstract][Full Text] [Related]
18. Second multicenter, randomized, double-blind, parallel-group evaluation of effectiveness and safety of intravesical sodium chondroitin sulfate compared with inactive vehicle control in subjects with interstitial cystitis/bladder pain syndrome. Nickel JC; Hanno P; Kumar K; Thomas H Urology; 2012 Jun; 79(6):1220-4. PubMed ID: 22516357 [TBL] [Abstract][Full Text] [Related]
19. Multiple intravesical instillations of low-dose resiniferatoxin in the treatment of refractory interstitial cystitis. Peng CH; Kuo HC Urol Int; 2007; 78(1):78-81. PubMed ID: 17192738 [TBL] [Abstract][Full Text] [Related]
20. Hyaluronic acid improves pain symptoms more than bladder storage symptoms in women with interstitial cystitis. Hung MJ; Tsai CP; Lin YH; Huang WC; Chen GD; Shen PS Taiwan J Obstet Gynecol; 2019 May; 58(3):417-422. PubMed ID: 31122535 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]